Taglich Brothers Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Taglich Brothers. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Taglich Brothers. Brokerage RankingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROITotal Ratings2 Last 12 MonthsBuy Ratings1 Last 12 MonthsSell Ratings0 Last 12 MonthsCompanies Covered2 Last 12 Months Country USA (NYSE & NASDAQ) USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Reporting Date Export to Excel CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetailsBGSFBGSF$7.20-0.1%6/23/2025H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeModerate Buy ➝ Strong-Buy00.00%View details for Taglich Brothers rating of BGSF (NYSE:BGSF) on 6/23/2025COSMCosmos Health$0.95+2.3%2/20/2024H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Cosmos Health (NASDAQ:COSM) on 2/20/2024BSGMBiosig Technologies$6.35+42.6%4/10/2023H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Biosig Technologies (NASDAQ:BSGM) on 4/10/2023SIDUSidus Space$1.083/27/2023H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Sidus Space (NASDAQ:SIDU) on 3/27/2023BSGMBiosig Technologies$6.35+42.6%9/15/2022J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Biosig Technologies (NASDAQ:BSGM) on 9/15/2022CREXCreative Realities$2.34+0.9%8/2/2022H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy00.00%View details for Taglich Brothers rating of Creative Realities (NASDAQ:CREX) on 8/2/2022UFPTUFP Technologies$192.77-4.4%11/11/2021J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy00.00%View details for Taglich Brothers rating of UFP Technologies (NASDAQ:UFPT) on 11/11/2021SLPSimulations Plus$15.25-3.8%11/25/2020H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgrade$76.00Speculative Buy ➝ Buy00.00%View details for Taglich Brothers rating of Simulations Plus (NASDAQ:SLP) on 11/25/2020BLINBridgeline Digital$1.339/24/2020H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Bridgeline Digital (NASDAQ:BLIN) on 9/24/2020UFPTUFP Technologies$192.77-4.4%9/1/2020J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy00.00%View details for Taglich Brothers rating of UFP Technologies (NASDAQ:UFPT) on 9/1/2020 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. APTAlpha Pro Tech$4.69-2.7%8/12/2020H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy00.00%View details for Taglich Brothers rating of Alpha Pro Tech (NYSE:APT) on 8/12/2020PERIPerion Network$9.83+0.3%8/12/2020J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeSpeculative Buy ➝ Buy00.00%View details for Taglich Brothers rating of Perion Network (NASDAQ:PERI) on 8/12/2020APTAlpha Pro Tech$4.69-2.7%8/13/2020H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated Rating$32.50Buy00.00%View details for Taglich Brothers rating of Alpha Pro Tech (NYSE:APT) on 8/13/2020MEDSTRxADE HEALTH$0.89+0.4%6/10/2020H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of TRxADE HEALTH (NASDAQ:MEDS) on 6/10/2020PHUNPhunware$2.90+0.7%5/19/2020H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Phunware (NASDAQ:PHUN) on 5/19/2020PERIPerion Network$9.83+0.3%11/8/2019J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Perion Network (NASDAQ:PERI) on 11/8/2019NEPHNephros$4.18+3.0%4/24/2019H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Nephros (NASDAQ:NEPH) on 4/24/2019SLPSimulations Plus$15.25-3.8%1/16/2019H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Speculative Buy00.00%View details for Taglich Brothers rating of Simulations Plus (NASDAQ:SLP) on 1/16/2019BGSFBGSF$7.20-0.1%11/6/2018H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of BGSF (NYSE:BGSF) on 11/6/2018UFPTUFP Technologies$192.77-4.4%8/29/2018J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy00.00%View details for Taglich Brothers rating of UFP Technologies (NASDAQ:UFPT) on 8/29/2018PERIPerion Network$9.83+0.3%8/13/2018J. NobileSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Perion Network (NASDAQ:PERI) on 8/13/2018PERIPerion Network$9.83+0.3%8/14/2018 Initiated Coverage$6.75Buy00.00%View details for Taglich Brothers rating of Perion Network (NASDAQ:PERI) on 8/14/2018LWAYLifeway Foods$26.36-2.0%6/18/2018 Reiterated Rating$14.10Speculative Buy00.00%View details for Taglich Brothers rating of Lifeway Foods (NASDAQ:LWAY) on 6/18/2018MEDSTRxADE HEALTH$0.89+0.4%10/6/2017H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of TRxADE HEALTH (NASDAQ:MEDS) on 10/6/2017ZYXIZynex$1.558/21/2017H. HalpernSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Zynex (NASDAQ:ZYXI) on 8/21/2017AYTUAytu BioPharma$2.44+3.0%2/17/2017J. NobleSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSpeculative Buy00.00%View details for Taglich Brothers rating of Aytu BioPharma (NASDAQ:AYTU) on 2/17/2017WYNNWynn Resorts$129.52+0.7%10/5/2015 Upgrade$54.00 ➝ $68.00Underperform ➝ Market Perform00.00%View details for Taglich Brothers rating of Wynn Resorts (NASDAQ:WYNN) on 10/5/2015SHOOSteven Madden$32.02-2.1%10/1/2015 Upgrade$28.67 ➝ $29.33Market Perform ➝ Outperform00.00%View details for Taglich Brothers rating of Steven Madden (NASDAQ:SHOO) on 10/1/2015LPTHLightPath Technologies$7.24+14.4%11/19/2014 Reiterated Rating$1.70 ➝ $1.64Speculative Buy00.00%View details for Taglich Brothers rating of LightPath Technologies (NASDAQ:LPTH) on 11/19/2014NTWKNetSol Technologies$4.57-10.4%11/18/2014 Boost Price Target$4.60 ➝ $5.05Speculative Buy00.00%View details for Taglich Brothers rating of NetSol Technologies (NASDAQ:NTWK) on 11/18/2014INUVInuvo$3.57+3.5%5/28/2014 Initiated Coverage$14.50Speculative Buy00.00%View details for Taglich Brothers rating of Inuvo (NYSE:INUV) on 5/28/2014LWAYLifeway Foods$26.36-2.0%5/28/2013 Boost Price Target$14.10 ➝ $19.65Speculative Buy00.00%View details for Taglich Brothers rating of Lifeway Foods (NASDAQ:LWAY) on 5/28/2013LWAYLifeway Foods$26.36-2.0%4/18/2013 Boost Price Target$11.50 ➝ $14.10Speculative Buy00.00%View details for Taglich Brothers rating of Lifeway Foods (NASDAQ:LWAY) on 4/18/2013LWAYLifeway Foods$26.36-2.0%4/9/2013 Reiterated Rating$11.50 ➝ $14.10Buy00.00%View details for Taglich Brothers rating of Lifeway Foods (NASDAQ:LWAY) on 4/9/2013HCIHCI Group$181.53-2.0%4/1/2013 Boost Price Target$27.35 ➝ $31.95Buy00.00%View details for Taglich Brothers rating of HCI Group (NYSE:HCI) on 4/1/2013CVMCEL-SCI$8.67-2.8%2/20/2013 Initiated CoverageBuy00.00%View details for Taglich Brothers rating of CEL-SCI (NYSE:CVM) on 2/20/2013ASYSAmtech Systems$9.04-4.8%12/17/2012 DowngradeNeutral00.00%View details for Taglich Brothers rating of Amtech Systems (NASDAQ:ASYS) on 12/17/2012LWAYLifeway Foods$26.36-2.0%11/28/2012 Reiterated Rating$11.50Buy00.00%View details for Taglich Brothers rating of Lifeway Foods (NASDAQ:LWAY) on 11/28/2012ALCOAlico$33.54-1.2%11/8/2012 Initiated Coverage$35.00Buy00.00%View details for Taglich Brothers rating of Alico (NASDAQ:ALCO) on 11/8/2012 MarketBeat Community Rating for Taglich BrothersCommunity Ranking: 2.6 out of 5 (2.6 of 5 stars)Outperform Votes: 53,992 (Vote Outperform)Underperform Votes: 51,588 (Vote Underperform)Total Votes: 105,580MarketBeat's community ratings are surveys of what our community members think about Taglich Brothers and other research firms. Vote "Outperform" if you believe Taglich Brothers's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Taglich Brothers's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
